DarioHealth Corp Stock News

BOSTON, Oct. 18, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical thera

The stock price of DarioHealth Corp (NASDAQ: DRIO) increased by over 10% pre-market today. This is why it happened.

NEW YORK, Oct. 14, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has entered into an agreement with one of the lar

NEW YORK, Oct. 7, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the Unite

NEW YORK, Sept. 24, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat duri

NEW YORK, Sept. 17, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Mane

Dario Continues to Expand its Employer Contracts Across Broad Range of Solutions NEW YORK, Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (

NEW YORK, Sept. 8, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide it

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has finalized a contract with PeopleOne Health to be the digital behavioral health solution of choice for patients effe

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q2 2021 Results - Earnings Call Transcript

DarioHealth Corp (NASDAQ: DRIO) reported second-quarter FY21 revenue growth of 194% year-on-year to $5.26 million, beating the analyst consensus of $5.11 million. The non-GAAP billings rose 186% Y/

Shares of DarioHealth (NASDAQ:DRIO) fell 0.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to ($0.68), whic

NEW YORK, Aug. 16, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provi

NEW YORK, Aug. 12, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care

NEW YORK, July 27, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that